Overall rank by patents
#24,306
Across all tracked assignees
USPTO PatentsView assignee record - 11 granted patents across 1 technology areas, active 2017–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: H04L (TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION).
The verdict
Exinda holds 11 US patents across 1 technology areas, rank #24,306 of 50,000 tracked assignees.
Exinda Networks PTY, Ltd. has been granted 11 US utility patents between 2017 and 2025, placing Exinda Networks PTY, Ltd. at rank #24,306 across all assignees tracked by PlainPatent. This portfolio spans 1 distinct Cooperative Patent Classification (CPC) subclasses, averaging 21.7 claims per patent with primary concentration in H04L (TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION). As a US Corporation, Exinda Networks PTY, Ltd. is one of the more focused assignees in the PatentsView dataset. By volume, Exinda sits between Eutropics Pharmaceuticals, Inc. (11 patents, rank #24,302) and Family Inada Co., Ltd. (11 patents, rank #24,310) - the closest US assignees by grant volume. The composite Innovation Score of 27.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 6 grants, compared with 5 in the 2015–2019 window, a +20% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Exinda Networks PTY, Ltd.'s 21.7 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while specialization in 1 subclass reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Exinda Networks PTY, Ltd. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Eutropics Pharmaceuticals, Inc.
11 patents
EverPro Technologies Company Limited
11 patents
Everbridge, Inc.
11 patents
Evolv Technologies, Inc.
11 patents
ExlService Holdings, Inc.
11 patents
Ezaki Glico Co. Ltd.
11 patents
F-star Therapeutics Limited
11 patents
FAMILY INADA CO., LTD.
11 patents
Exinda Networks PTY, Ltd.
11 patents
What this shows Exinda holds 11 patents at rank #24,306, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Exinda's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
27 Top 78% higher than 22% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 1 | 9.1% |
| 2019 | 4 | 36.4% |
| 2020 | 3 | 27.3% |
| 2022 | 1 | 9.1% |
| 2023 | 1 | 9.1% |
| 2025 | 1 | 9.1% |
Top 1 of 1 technology areas
Overall rank by patents
#24,306
Across all tracked assignees
27.1 out of 100
How to use this portfolio
Exinda's 11 grants land it in the top 78% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.